1. Home
  2. CDNA vs WRBY Comparison

CDNA vs WRBY Comparison

Compare CDNA & WRBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CareDx Inc.

CDNA

CareDx Inc.

N/A

Current Price

$84.86

Market Cap

3.3B

Sector

Health Care

ML Signal

N/A

Logo Warby Parker Inc.

WRBY

Warby Parker Inc.

N/A

Current Price

$24.43

Market Cap

3.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CDNA
WRBY
Founded
1998
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Ophthalmic Goods
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
3.1B
IPO Year
2007
2021

Fundamental Metrics

Financial Performance
Metric
CDNA
WRBY
Price
$84.86
$24.43
Analyst Decision
Buy
Buy
Analyst Count
7
13
Target Price
★ $65.33
$31.00
AVG Volume (30 Days)
1.3M
★ 2.5M
Earning Date
10-29-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 105.88
EPS
★ 2.45
0.06
Revenue
$48,324,000.00
★ $871,905,000.00
Revenue This Year
$30.36
$11.25
Revenue Next Year
$6.23
$16.89
P/E Ratio
★ $33.32
$410.33
Revenue Growth
★ 18.93
13.04
52 Week Low
$14.27
$14.96
52 Week High
$73.43
$31.00

Technical Indicators

Market Signals
Indicator
CDNA
WRBY
Relative Strength Index (RSI) 79.73 44.72
Support Level $17.30 $23.19
Resistance Level N/A $27.25
Average True Range (ATR) 4.65 1.28
MACD 0.83 -0.12
Stochastic Oscillator 80.27 29.16

Price Performance

Historical Comparison
CDNA
WRBY

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

About WRBY Warby Parker Inc.

Warby Parker Inc is a mission-driven, lifestyle brand that operates at the intersection of design, technology, healthcare, and social enterprise. The Company provides holistic vision care by offering eyewear, contacts, and eye care directly to consumers through its integrated, omnichannel platform. The company predominantly derives revenue from the sales of eyewear products, optical services, and accessories. The firm sells products and services through its stores, website, and mobile apps. Revenue generated from eyewear products includes the sales of prescription and non-prescription optical glasses and sunglasses, contact lenses, eyewear accessories, and expedited shipping charges.

Share on Social Networks: